Forecasting Analyst II at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

3-5 years' experience in a similar business analyst role, preferably within the biopharma or pharmaceutical industry
Bachelor’s or master’s degree in pharmacy, technology or engineering, with a strong record of analytic and quantitative work
Deep experience with short-term and strategic forecast in Pharma industry
Proficiency in statistical analysis techniques, predictive modeling, and forecasting methodologies
Experience operating successfully in a complex organizational environment
Experience interacting with senior management, understanding, anticipating, and fulfilling their insight/analytical information requirements
Strong verbal/written skills, with the ability to effectively communicate with and strategically impact senior leadership
Experience in working with US healthcare datasets (e.g. IQVIA/SHS National, Subnational, Patient Claims), data processing and visualization

Responsibilities

Develop and maintain forecasting models and techniques to project sales, demand and market trends for products
Conduct analysis and interpretation of complex data sets to derive meaningful insights and recommendations to the key forecasting assumptions/decisions
Perform statistical analyses, data mining and predictive modelling to uncover trends and correlations
Partner closely with Commercial Data Analyst teams to drive value for stakeholders by optimizing/managing business processes, synthesizing data at regular intervals, maintaining high quality standards, applying automation using cutting edge technology, performing analyses, updating business rules, presenting results to stakeholders, answering queries on deliverables and generating focused insights
Collaborate with Business stakeholders to identify goals and KPIs to develop analytical frameworks
Collaborate with Finance team to ensure efficient forecasting processes, data/information sharing, and insight generation related to forecast performance
Collect real-world data from multiple sources to support business strategies and decision-making
Prepare reports and presentations to communicate findings, insights, and recommendations to your team members
Stay up to date with industry trends, best practices and emerging technologies

Skills

Forecasting Models

Advanced Analytics

Data Analysis

Sales Forecasting

Demand Forecasting

Market Trend Analysis

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free